After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...
Grail is preparing to file for FDA approval of its Galleri test for detecting multiple cancers from a single blood test after seeing positive results in a second phase 3 trial. Galleri is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback